Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study.

Paul ValensiAntoine AvignonAriane SultanBernard ChanuMinh Tuan NguyenEmmanuel Cosson

Published in: Cardiovascular diabetology (2016)

Atherogenic dyslipidemia was associated with an increased risk of SMI and silent CAD in patients with type 2 diabetes and LDL cholesterol levels <3.35 mmol/L. Specific management of atherogenic dyslipidemia might help reducing the high residual burden of cardiovascular disease.

Keyphrases

low density lipoprotein
coronary artery disease
cardiovascular disease
cardiovascular events
percutaneous coronary intervention
risk factors
coronary artery bypass grafting
type diabetes
heart failure
metabolic syndrome
atrial fibrillation
left ventricular
transcatheter aortic valve replacement
aortic valve